This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Researchers from multiple institutions in Spain conducted a randomized, double-blind, placebo-controlled trial to determine if dexamethasone (DXM) reduced recovery time in pediatric patients with parapneumonic pleural effusion. Children who were 1 month to 14 years of age and were hospitalized with community-acquired pneumonia (CAP) and pleural effusion at 1 of 9 study sites were eligible. CAP was defined as fever >38°C (>100.4°F), cough, and parenchymal infiltrate at chest radiography. Pleural effusions were diagnosed via thoracic ultrasonography (US) and classified as either complicated (pH level <7.2, loculations or septations at US, or bacteria on Gram stain) or simple (no features of complicated effusions present).
Participants were randomized to receive either 8 intravenous doses of DXM (0.25 mg/kg every 6 hours) or the corresponding volume of …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.